Presentation mvcc 2010_ver_april_15_2010_slide_share

444 views
406 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
444
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
15
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Presentation mvcc 2010_ver_april_15_2010_slide_share

  1. 1. Monterrey Venture Capital Conference<br />ANGEL VENTURES MÉXICO, S.C.<br />CLUB DE INVERSIONISTAS DE MÉXICO, A.C.<br />BPS-CardiacMedicalDevicebyknavii.<br />
  2. 2. BPS-Cardiac: ThePain<br /><ul><li>People who needs CVBP (Central Venous Blood Pressure Measurement).</li></ul>Intensive Care Units (ICU)<br />Heart attack<br />Catheterization: Expensive & Risky, Procedure<br />Potential Problems: Infections, Fluid shifts.<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  3. 3. BPS-Cardiac: ValueProposition<br />A painless, low cost, technology to measure CVBP.<br />Stake Holder<br />Patient and his Family<br />Physician & Nurse<br />Payers (Public & Private)<br />Hospitals<br />Government Regulator<br />Value Created<br />Lessen Pain and suffering<br />Less en Lawsuitsfor wrong catheterizations.<br />Reduce the currentCost of the procedure<br />Increase the productivity (faciilities)<br />Secure and effective treatments (Law/Reg.)<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  4. 4. BPS-Cardiac: Technology<br />A disruptive non-invasive technology that measure CVBP (Lab scale prototype is ready!!!!)<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  5. 5. BPS-Cardiac: TechnologyCompetitiveness<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  6. 6. BPS-Cardiac: MarketOpportunity<br />PotentialMarket: US Market (ICU Beds)<br />CAGR 12.3%<br />Hospitals2<br />2,754<br />BPS-Cardicac:<br />$4,000<br />$491 <br />MUSD<br />Beds in Hospitals2<br /> 951,045<br />Intensive Care Beds2<br />122,810<br />BCC Research Report Code HLC019D, Published: August 2009<br /> includes, equipment disposal and services.<br />(2) American Hospital Association: Fast Facts on US Hospitals<br /> 2009 report.<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  7. 7. BPS-Cardiac: Business Model<br />Goal: License the technology to a major Medical Device Manufacturer<br />GE Medical Systems<br />Johnson & Johnson Medical System<br />Baxter <br />Where We add value to the Business Model?<br />Disruptive Technology<br />Patent<br />Exclusivity for US/Mexico Markets<br />Regulatory Compliance<br />Paperwork<br />USPTO, FDA, COFEPRIS<br />Clinical trials<br />Manufacturing & Testing (1,000 Units)<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  8. 8. BPS-Cardiac: TheTeam<br />Fernando Huerta<br />Marco Sanchez<br />Viridiana Omana<br />Michele Gonzalez<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  9. 9. BPS-Cardiac: Financials (ValueCreation)<br />Product<br />Target Market US/Mex:<br />Units Solds: 28,179<br />Revenue: $112M usd<br />Royalties: $13.5 M usd<br />NPV @12%: Investors, Founders & MDM: $28.6M usd<br />Investors: 4.0 M usd<br />Founders: $9.4M usd<br />Medical Device Manufacturer: 15.2M usd<br />Payback:<br />Investors & Founders: 3.9 years<br />Device Manufacter: 1.2 years<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  10. 10. BPS-Cardiac: Funds Required<br />VC investment in Medical Devices Startups $719MUSD / Q4 2009 <br />$ 1.56 MUSD<br />Equity: 30%<br />Funds used for:<br />a) Exclusivity (US/Mex)<br />b) FDA/COFEPRIS Approvals<br />c) USPTO filing<br />d) Clinical Trials<br />e) Manufacturer 1,000 units<br />f) Due diligence for contracting MDM<br />Exit: Selling IP to a major Medical <br />Device Manufacturer.<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  11. 11. BPS-Cardiac: Status<br />Negotiation: <br />Medical Dev. Manufacturer (MDM)<br />Licensing contract signed<br />MDM Ready for Sale.<br />Manufacturing 1,000 Units<br />Clinical Trials<br />FDA/COFEPRIS Approvals<br />Raise Funds: $1.56 MUSD<br />IP Filing<br />US/Mex<br />Massive<br />Commercialization<br />Raising Capital<br />$1.56 MUSD<br />R&D<br />Royalties<br />2005 – 2009<br />2010<br />2011<br />2012<br />2013<br />Pain<br />Val.<br />Prop.<br />Tech.<br />Mkt.<br />Opp.<br />Bus.<br />Mod.<br />Team<br />Fin.<br />Status<br />
  12. 12. BPS Cardiac: Remember!!!!!! <br />This is an Excellent Opportunity to invest in a non-invasive low risk disruptive technology that saves people lives.<br />Business Upsides: More applications, can be expanded worldwide and with a potential of developing a recurrent business disposals.<br />That requires an investment of $1.56 MUSD used for key success activities. (IP Lawers and filing and device manufacturing)<br />And creates an economic value of $28.6M USD.<br />
  13. 13. BPS-Cardiac: Thanks you!!!!<br />Information:<br />fhuertamty@gmail.com<br />Mobile: +52 +81 1516-8469<br />

×